After surgery for Cushing’s disease, very low levels of cortisol in the morning strongly predict that a patient will…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
An artificial intelligence (AI)-designed small molecule that targets the NR3C1 gene may offer a safer, more effective treatment for Cushing’s…
April is Cushing’s Awareness Month, a global effort during which advocacy groups — such as the Cushing’s Support &…
A urine test that measures cortisol, cortisone, and dexamethasone simultaneously can improve the reliability of 24-hour urinary free cortisol (UFC)…
Relacorilant, an oral treatment being developed by Corcept Therapeutics, appears to be safe and effective for controlling high…
In Cushing’s disease, an imaging technique that uses a radioactive tracer targeting the CXCR4 protein may help locate the…
Isturisa (osilodrostat) is now available in Canada for adults with Cushing’s disease who have persistent or recurrent high…
Although acinic cell carcinoma — a cancer of the glands that produce saliva — is usually considered low risk,…
Persistent symptoms during corticosteroid tapering should prompt evaluation for an internal source of excess cortisol — usually from the adrenal…
A woman with Cushing’s disease developed overlapping heart symptoms, a case researchers said highlights the need for early diagnosis…